Compound ID | 352
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Pseudomonas sp. and Staphylococcus aureus |
| Description: | Injectable cephalosporin |
| Institute where first reported: | Mochida Pharmaceutical; Ajinomoto; GSK, USA |
| Year first mentioned: | 1986 |
| Highest development stage: | Phase 1 |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6540697 |
| Guide to Pharmacology: | M14659 |
| Citations: |
|